Neomycin reduces the intestinal production of ammonia from glutamine. 1994

R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
Department of Physiology and Biophysics, Finch University of Health Sciences, Chicago Medical School, IL 60064, USA.

The mechanism by which neomycin treatment reduces circulating ammonia concentrations was studied in normal and portacaval shunted rats. Rats were given neomycin for 3 days and then fasted for 24 hours to eliminate feces. Neomycin decreased arteriovenous differences of ammonia across the intestine even when the intestines were empty. Neomycin treatment lowered the activity of glutaminase in the intestinal mucosa and the rate of ammonia production from glutamine by isolated intestinal segments. The intestines from portacaval shunted rats had higher glutaminase activity (by 57%), and produced ammonia from glutamine at a greater rate (by 31%), than intestines from controls. Neomycin treatment lowered glutaminase activity and ammonia production in shunted rats, but glutaminase activity still remained higher than in controls (by 23%). The data indicate that the mechanism by which neomycin lower plasma ammonia is owing, at least in part, to a direct effect on the intestines. Specifically, neomycin causes a reduction in mucosal glutaminase activity and thereby decreases the ability of the mucosa to consume glutamine and produce ammonia.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008297 Male Males
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D011167 Portacaval Shunt, Surgical Surgical portasystemic shunt between the portal vein and inferior vena cava. Eck Fistula,Portacaval Anastomosis,Portacaval Shunt,Shunt, Surgical Portacaval,Surgical Portacaval Shunt,Anastomoses, Portacaval,Anastomosis, Portacaval,Fistula, Eck,Portacaval Anastomoses,Portacaval Shunts,Portacaval Shunts, Surgical,Shunt, Portacaval,Shunts, Portacaval,Shunts, Surgical Portacaval,Surgical Portacaval Shunts
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D005972 Glutaminase Phosphate-Activated Glutaminase,Glutaminase, Phosphate-Activated,Phosphate Activated Glutaminase
D005973 Glutamine A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. D-Glutamine,L-Glutamine,D Glutamine,L Glutamine
D000641 Ammonia A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
March 1968, The Journal of physiology,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
August 1986, Infusionstherapie und klinische Ernahrung,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
June 2001, Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
June 1959, A.M.A. archives of surgery,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
July 2003, The Journal of experimental biology,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
April 1986, Life sciences,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
January 1971, The American journal of physiology,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
March 1973, Gut,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
September 2019, Redox biology,
R A Hawkins, and J Jessy, and A M Mans, and A Chedid, and M R DeJoseph
October 1980, Biochemical Society transactions,
Copied contents to your clipboard!